Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma

PURPOSE: Given that the novel coronavirus disease (COVID-19) pandemic has disrupted operations globally, an institution’s ability to repeat transarterial chemoembolization (TACE) for patients with hepatocellular carcinoma (HCC) has also been affected. The aim of this study was to evaluate the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Zhi-Cheng, Chen, Li, Zhong, Bin-Yan, Zhu, Hai-Dong, Zeng, Chu-Hui, Li, Rui, Guo, Jin-He, He, Shi-Cheng, Deng, Gang, Zhu, Xiao-Li, Ni, Cai-Fang, Teng, Gao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134679/
https://www.ncbi.nlm.nih.gov/pubmed/34026598
http://dx.doi.org/10.3389/fonc.2021.602700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134679/
https://www.ncbi.nlm.nih.gov/pubmed/34026598
http://dx.doi.org/10.3389/fonc.2021.602700

Ejemplares similares